calendar
18,993 catalysts · 18,987 approval · 5,063 phase readout · 5,000 device 510k · 4,728 grant · 2,469 8k filing · 2,000 device pma
18,993 catalysts · 18,987 approval · 5,063 phase readout · 5,000 device 510k · 4,728 grant · 2,469 8k filing · 2,000 device pma
Sponsor: GLAXOSMITHKLINE. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION
Sponsor: SPECGX LLC. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET. Route: ORAL
Sponsor: APOTEX INC. Form: TABLET. Route: ORAL
Sponsor: KENVUE BRANDS. Form: TABLET. Route: ORAL
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVARTIS. Form: CAPSULE. Route: ORAL
Sponsor: CEPHALON. Form: TROCHE/LOZENGE. Route: TRANSMUCOSAL
Sponsor: PHARMOBEDIENT. Form: CAPSULE. Route: ORAL
Sponsor: RHODES PHARMS. Form: SOLUTION. Route: ORAL
Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL
Sponsor: ORGANON. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET. Route: ORAL
Sponsor: TEVA PHARMS USA. Form: CAPSULE. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: APOTEX. Form: TABLET. Route: ORAL
Sponsor: CHARTWELL. Form: TABLET. Route: ORAL
Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION
Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION
Sponsor: CEPHALON. Form: TROCHE/LOZENGE. Route: TRANSMUCOSAL
Sponsor: US ARMY. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: CAPSULE. Route: ORAL
Sponsor: NOVARTIS. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVARTIS. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVARTIS. Form: SOLUTION. Route: ORAL
Sponsor: NOVARTIS. Form: SOLUTION. Route: ORAL
Sponsor: KENVUE BRANDS. Form: SOLUTION. Route: TOPICAL
Sponsor: PURDUE PHARMA LP. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: CAPSULE. Route: ORAL
Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION
Sponsor: QUAGEN. Form: TABLET. Route: ORAL
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: MYLAN PHARMS INC. Form: CAPSULE. Route: ORAL
Sponsor: RHODES PHARMS. Form: TABLET. Route: ORAL
Sponsor: CHEPLAPHARM. Form: TABLET. Route: ORAL
Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL
Sponsor: ABBVIE. Form: SUSPENSION/DROPS. Route: OPHTHALMIC
Sponsor: PHARMOBEDIENT CNSLTG. Form: SYRUP. Route: ORAL
Sponsor: LILLY. Form: INJECTABLE. Route: INJECTION
Sponsor: EUROFARMA. Form: SUSPENSION. Route: TOPICAL
Sponsor: EUROFARMA. Form: SUSPENSION. Route: TOPICAL
Sponsor: EUROFARMA. Form: CREAM. Route: TOPICAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL
Sponsor: PF PRISM CV. Form: POWDER. Route: INTRAVENOUS
Sponsor: TEVA PHARMS USA. Form: CAPSULE. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: CAPSULE. Route: ORAL